Jubilant Life Sciences

Jubilant Life Sciences – Q1’FY20 Results

  Revenue at Rs. 2,182 Crore up 5% YoY; EBITDA at Rs 444 Crores down 1% YoY PAT at Rs 185…

5 years ago

Sudarshan Pharma Industries Ltd.: The Pharma Giant in the Making Announces IPO and Expansion in the MENA Region

Mumbai, June 01, 2019: In a cloud of an organised healthcare ecosystem, the demand for speciality chemicals and pharmaceutical products…

5 years ago

Jubilant Life Sciences – Q4 & 12M’FY19 Results

  JUBILANT REPORTS RECORD PERFORMANCE IN FY'19 Revenue up 21% YoY to Rs. 9,111 Crore; EBITDA up 14% YoY to Rs 1,775…

6 years ago

Jubilant Life Sciences – Q3 & 9M’FY19 Results

New  Delhi, February 02, 2019:  JUBILANT REPORTSRECORD PERFORMANCE IN Q3’FY19 Revenue up 15% YoY to Rs. 2,377 Crore; EBITDA up…

6 years ago

Jubilant Life Sciences Ltd updates on cancellation of distillery license

Mumbai, March 07, 2018: Jubilant Life Sciences said that The Commissioner of State Excise, Maharashtra has passed an order dated March…

7 years ago